These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33569042)

  • 1. Pain Control by Targeting Oxidized Phospholipids: Functions, Mechanisms, Perspectives.
    Oehler B; Brack A; Blum R; Rittner HL
    Front Endocrinol (Lausanne); 2020; 11():613868. PubMed ID: 33569042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na
    Martin C; Stoffer C; Mohammadi M; Hugo J; Leipold E; Oehler B; Rittner HL; Blum R
    Front Mol Neurosci; 2018; 11():7. PubMed ID: 29410612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation.
    Oehler B; Kistner K; Martin C; Schiller J; Mayer R; Mohammadi M; Sauer RS; Filipovic MR; Nieto FR; Kloka J; Pflücke D; Hill K; Schaefer M; Malcangio M; Reeh PW; Brack A; Blum R; Rittner HL
    Sci Rep; 2017 Jul; 7(1):5447. PubMed ID: 28710476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.
    Gao D; Podrez EA
    Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
    Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
    Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPs and pain.
    Dai Y
    Semin Immunopathol; 2016 May; 38(3):277-91. PubMed ID: 26374740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.
    Palmieri M; Kim HN; Gomez-Acevedo H; Que X; Tsimikas S; Jilka RL; Manolagas SC; Witztum JL; Ambrogini E
    J Bone Miner Res; 2021 Jan; 36(1):170-185. PubMed ID: 32990984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis).
    Handa JT; Tagami M; Ebrahimi K; Leibundgut G; Janiak A; Witztum JL; Tsimikas S
    Trans Am Ophthalmol Soc; 2015; 113():T5. PubMed ID: 26538774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids.
    Bochkov V; Schoenenberger AW; Oskolkova O; Toth U; Stöckl J; Majdic O; Daci A; Resink TJ; Erne P; Philippova M
    Biomark Med; 2016 Aug; 10(8):797-810. PubMed ID: 27416002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRP channels: potential drug target for neuropathic pain.
    Marwaha L; Bansal Y; Singh R; Saroj P; Bhandari R; Kuhad A
    Inflammopharmacology; 2016 Dec; 24(6):305-317. PubMed ID: 27757589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
    Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
    J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
    Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
    Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central Nervous System Targets: Supraspinal Mechanisms of Analgesia.
    Bannister K; Dickenson AH
    Neurotherapeutics; 2020 Jul; 17(3):839-845. PubMed ID: 32700132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central activation of TRPV1 and TRPA1 by novel endogenous agonists contributes to mechanical allodynia and thermal hyperalgesia after burn injury.
    Green D; Ruparel S; Gao X; Ruparel N; Patil M; Akopian A; Hargreaves K
    Mol Pain; 2016; 12():. PubMed ID: 27411353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a).
    Yeang C; Hung MY; Byun YS; Clopton P; Yang X; Witztum JL; Tsimikas S
    J Clin Lipidol; 2016; 10(3):594-603. PubMed ID: 27206947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
    Tsimikas S; Aikawa M; Miller FJ; Miller ER; Torzewski M; Lentz SR; Bergmark C; Heistad DD; Libby P; Witztum JL
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):175-81. PubMed ID: 17082490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.
    Leitinger N
    Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity.
    Tsimikas S; Witztum JL
    Curr Opin Lipidol; 2008 Aug; 19(4):369-77. PubMed ID: 18607184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.